esha
☆    

2011-03-08 13:52
(5585 d 22:25 ago)

Posting: # 6719
Views: 4,283
 

 Acarbose and Metformin Study [Design Issues]

Can we administer glucose solution to prevent hypoglycemia in bioequivalence of Acarbose combination with metformin study?
We are going to estimate change in serum glucose concentration by PD end point for Acarbose. Will glucose administration affect the study result?


Edit: Please follow the Forum's Policy in the future. [Helmut]
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2011-03-08 14:15
(5585 d 22:02 ago)

@ esha
Posting: # 6721
Views: 3,415
 

 Acarbose and Metformin Study

Dear Esha!

❝ Can we administer glucose solution to prevent hypoglycemia in bioequivalence of Acarbose combination with metformin study?


You have to. Please search the forum in the future - you would have found this post. See also FDA's guidances on acarbose and metformin (IR tablets, ER tablets).

❝ We are going to estimate change in serum glucose concentration by PD end point for Acarbose. Will glucose administration affect the study result?


Likely. That's a very tricky situation, because the PD endpoint of arcabose will be influenced by the effect of metformin. To be honest, I have not the slightest idea how you could demonstrate BE based on PD of arcabose and PK of metformin simultaneously.
:confused:

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
122 visitors (0 registered, 122 guests [including 16 identified bots]).
Forum time: 13:17 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5